ArticleCancer immunology, immunotherapy : CII2024

Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study.

Tomoko Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.